Does corticosteroid treatment during the pre and postnatal periods affect the neurodevelopmental outcome of premature newborns?

Biomédica : revista del Instituto Nacional de Salud
Marita LardónEduardo Narbona

Abstract

Glucocorticoids, widely used in the perinatal period, may be associated with adverse neurodevelopmental effects. To analyze neurodevelopmental outcomes in a cohort of very low birth weight newborns treated with antenatal and/or postnatal corticosteroids. This was a prospective cohort study in which we included all very low birth weight babies admitted to the neonatal intensive care unit of a tertiary hospital between 2008 and 2013. We compared the neurodevelopment among very low birth-weight newborns who did not receive prenatal corticosteroid therapy and those who received a complete course (two doses of 12 mg betamethasone) and an incomplete course (one dose), and between those who did not receive postnatal corticosteroid therapy and those who received it (systemic dexamethasone after the first week of life). Motor, neurosensory and cognitive functions, as well as behavior disorders during the first two years of age were evaluated. A total of 225 very low birth weight newborns were analyzed; 83.6% received prenatal corticosteroid therapy (24% incomplete treatment schedule and 59.6% complete schedule). Only 13.3% received systemic dexamethasone during the postnatal period. Neurological monitoring was performed corticosteroid t...Continue Reading

References

Oct 21, 2000·Archives of Disease in Childhood. Fetal and Neonatal Edition·E S ShinwellE Gottfried
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·A H Jobe, E Bancalari
Feb 5, 2002·Pediatrics·UNKNOWN Committee on Fetus and Newborn
Jul 21, 2006·The Cochrane Database of Systematic Reviews·D Roberts, S Dalziel
Dec 15, 2007·Journal of Child Neurology·Howard NeedelmanJ B Bodensteiner
Feb 5, 2008·Pediatrics·Ben H LeeUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Feb 11, 2009·Pediatrics·Deanne Wilson-CostelloUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Jul 2, 2009·Acta Obstetricia Et Gynecologica Scandinavica·Lena ErikssonHelle Kieler
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Henry L HallidayLex W Doyle
Sep 25, 2010·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·P-H JarreauA Castot
Oct 19, 2011·International Journal of Pediatrics·Sachin GuptaTsu F Yeh
Jun 12, 2012·Archives of Disease in Childhood. Fetal and Neonatal Edition·Jeanie Ling CheongUNKNOWN Victorian Infant Collaborative Study Group
Apr 10, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Sanjay ChawlaGirija Natarajan
Aug 31, 2013·The Cochrane Database of Systematic Reviews·Fiona C BrownfootCaroline A Crowther
Sep 3, 2013·The Journal of Pediatrics·Ann R StarkUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Oct 22, 2013·Archives of Disease in Childhood. Fetal and Neonatal Edition·D WongUNKNOWN NICUS Network
Jan 28, 2014·Current Opinion in Obstetrics & Gynecology·Ewa Romejko-WolniewiczKrzysztof Czajkowski
May 16, 2014·The Cochrane Database of Systematic Reviews·Lex W DoyleHenry L Halliday
May 16, 2014·The Cochrane Database of Systematic Reviews·Lex W DoyleHenry L Halliday
May 21, 2015·Archives of Gynecology and Obstetrics·Ken MiyazakiMasanori Fujimura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.